Madhumita Bogdan
About Madhumita Bogdan
Madhumita Bogdan is a Principal Investigator and Director at Deciphera Pharmaceuticals, where she leads drug discovery programs focusing on kinase inhibitors. She has extensive experience in cancer research, having held positions at institutions such as ProNAi Therapeutics, Lycera, Harvard University, and the University of Michigan.
Work at Deciphera Pharmaceuticals
Madhumita Bogdan serves as the Principal Investigator (Director) at Deciphera Pharmaceuticals, a role she has held since 2020. In this position, she independently leads drug discovery programs that focus on kinase inhibitors. She collaborates closely with the Translational Medicine team to develop biomarkers for cancer and immune cells. Additionally, she participates in the preparation of scientific abstracts and manuscripts, contributing to the organization's research output. Madhumita manages a team of four scientists, which includes both Master-level and PhD-level researchers, fostering a collaborative research environment.
Education and Expertise
Madhumita Bogdan earned her Bachelor of Science in Biology from Wayne State University, completing her studies from 2003 to 2007. She furthered her education by obtaining a Doctor of Philosophy (Ph.D.) in Pathology/Immunology from Boston University School of Medicine, where she studied from 2007 to 2012. Her academic background provides a strong foundation for her expertise in drug discovery and research in cancer biology.
Background
Madhumita Bogdan has a diverse professional background in biomedical research. She began her career as a Post-doctoral Research Fellow at Harvard University in 2012, where she worked for 11 months. Following this, she held a Post-doctoral Fellow position at the University of Michigan in the Department of Cell and Developmental Biology from 2013 to 2014. She then transitioned to Lycera, where she served as a Senior Scientist from 2016 to 2019 and later as Principal Scientist until 2020, before joining Deciphera Pharmaceuticals.
Achievements in Drug Discovery
Throughout her career, Madhumita Bogdan has been involved in significant drug discovery initiatives, particularly in the development of kinase inhibitors. Her leadership at Deciphera Pharmaceuticals emphasizes her role in advancing cancer research and therapeutic development. Her contributions to scientific literature through abstracts and manuscripts reflect her commitment to sharing knowledge and findings within the scientific community.